InvestorsHub Logo
Followers 831
Posts 120081
Boards Moderated 16
Alias Born 09/05/2002

Re: DewDiligence post# 15

Thursday, 03/09/2023 4:45:09 PM

Thursday, March 09, 2023 4:45:09 PM

Post# of 41
ALGS 4Q22 results—12/31/22 cash=$126M—4Q22 cash_burn=$16M:

https://finance.yahoo.com/news/aligos-therapeutics-reports-recent-business-210500130.html

ALGS’ COVID protease inhibitor, ALG-097558, is expected to start phase-1 in 2Q23.

No CC.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ALGS News